aluates Reports

$ 0.0

Automative

Global AI-assisted Drug Design (AIDD) Market Research Report 2023

Published Date: October 2023

Report Code: QYRE-Auto-28S14227

BUY CHAPTERS

Global AI-assisted Drug Design (AIDD) Market Research Report 2023

Code: QYRE-Auto-28S14227

Report

October 2023

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

AI-assisted Drug Design (AIDD) Market Size

According to new survey, global AI-assisted Drug Design (AIDD) market is projected to reach US$ 8890.4 million in 2029, increasing from US$ 1366.3 million in 2022, with the CAGR of 30.7% during the period of 2023 to 2029.

AI-assisted Drug Design (AIDD) Market

Artificial intelligence (AI) has the potential to revolutionize the drug discovery process,

offering improved efficiency, accuracy, and speed.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole AI-assisted Drug Design (AIDD) market research.

Key companies engaged in the AI-assisted Drug Design (AIDD) industry include IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine and NVIDIA, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of AI-assisted Drug Design (AIDD) were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole AI-assisted Drug Design (AIDD) market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global AI-assisted Drug Design (AIDD) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of AI-assisted Drug Design (AIDD) Market Report

Report Metric	Details
Report Name	AI-assisted Drug Design (AIDD) Market
Accounted market size in 2022	US$ 1366.3 million
Forecasted market size in 2029	US$ 8890.4 million
CAGR	30.7%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	Hardware Software Service
Segment by Application	Early Drug Discovery Preclinical Phase Clinical Phase Regulatory Approval
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine, NVIDIA, XtalPi, BPGbio, Owkin, CytoReason, Deep Genomics, Cloud Pharmaceuticals, BenevolentAI, Cyclica, Verge Genomics, Valo Health, Envisagenics, Euretos, BioAge Labs, Iktos, BioSymetrics, Evaxion Biotech, Aria Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is AI-assisted Drug Design (AIDD) Market growing?

Ans: The AI-assisted Drug Design (AIDD) Market witnessing a CAGR of 30.7% during the forecast period 2023-2029.

What is the AI-assisted Drug Design (AIDD) Market size in 2029?

Ans: The AI-assisted Drug Design (AIDD) Market size in 2029 will be US$ 8890.4 million.

Who are the main players in the AI-assisted Drug Design (AIDD) Market report?

Ans: The main players in the AI-assisted Drug Design (AIDD) Market are IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine, NVIDIA, XtalPi, BPGbio, Owkin, CytoReason, Deep Genomics, Cloud Pharmaceuticals, BenevolentAI, Cyclica, Verge Genomics, Valo Health, Envisagenics, Euretos, BioAge Labs, Iktos, BioSymetrics, Evaxion Biotech, Aria Pharmaceuticals

What are the Application segmentation covered in the AI-assisted Drug Design (AIDD) Market report?

Ans: The Applications covered in the AI-assisted Drug Design (AIDD) Market report are Early Drug Discovery, Preclinical Phase, Clinical Phase, Regulatory Approval

What are the Type segmentation covered in the AI-assisted Drug Design (AIDD) Market report?

Ans: The Types covered in the AI-assisted Drug Design (AIDD) Market report are Hardware, Software, Service

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI-assisted Drug Design (AIDD) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Hardware

1.2.3 Software

1.2.4 Service

1.3 Market by Application

1.3.1 Global AI-assisted Drug Design (AIDD) Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Early Drug Discovery

1.3.3 Preclinical Phase

1.3.4 Clinical Phase

1.3.5 Regulatory Approval

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global AI-assisted Drug Design (AIDD) Market Perspective (2018-2029)

2.2 AI-assisted Drug Design (AIDD) Growth Trends by Region

2.2.1 Global AI-assisted Drug Design (AIDD) Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 AI-assisted Drug Design (AIDD) Historic Market Size by Region (2018-2023)

2.2.3 AI-assisted Drug Design (AIDD) Forecasted Market Size by Region (2024-2029)

2.3 AI-assisted Drug Design (AIDD) Market Dynamics

2.3.1 AI-assisted Drug Design (AIDD) Industry Trends

2.3.2 AI-assisted Drug Design (AIDD) Market Drivers

2.3.3 AI-assisted Drug Design (AIDD) Market Challenges

2.3.4 AI-assisted Drug Design (AIDD) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI-assisted Drug Design (AIDD) Players by Revenue

3.1.1 Global Top AI-assisted Drug Design (AIDD) Players by Revenue (2018-2023)

3.1.2 Global AI-assisted Drug Design (AIDD) Revenue Market Share by Players (2018-2023)

3.2 Global AI-assisted Drug Design (AIDD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by AI-assisted Drug Design (AIDD) Revenue

3.4 Global AI-assisted Drug Design (AIDD) Market Concentration Ratio

3.4.1 Global AI-assisted Drug Design (AIDD) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI-assisted Drug Design (AIDD) Revenue in 2022

3.5 AI-assisted Drug Design (AIDD) Key Players Head office and Area Served

3.6 Key Players AI-assisted Drug Design (AIDD) Product Solution and Service

3.7 Date of Enter into AI-assisted Drug Design (AIDD) Market

3.8 Mergers & Acquisitions, Expansion Plans

4 AI-assisted Drug Design (AIDD) Breakdown Data by Type

4.1 Global AI-assisted Drug Design (AIDD) Historic Market Size by Type (2018-2023)

4.2 Global AI-assisted Drug Design (AIDD) Forecasted Market Size by Type (2024-2029)

5 AI-assisted Drug Design (AIDD) Breakdown Data by Application

5.1 Global AI-assisted Drug Design (AIDD) Historic Market Size by Application (2018-2023)

5.2 Global AI-assisted Drug Design (AIDD) Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America AI-assisted Drug Design (AIDD) Market Size (2018-2029)

6.2 North America AI-assisted Drug Design (AIDD) Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America AI-assisted Drug Design (AIDD) Market Size by Country (2018-2023)

6.4 North America AI-assisted Drug Design (AIDD) Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI-assisted Drug Design (AIDD) Market Size (2018-2029)

7.2 Europe AI-assisted Drug Design (AIDD) Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe AI-assisted Drug Design (AIDD) Market Size by Country (2018-2023)

7.4 Europe AI-assisted Drug Design (AIDD) Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific AI-assisted Drug Design (AIDD) Market Size (2018-2029)

8.2 Asia-Pacific AI-assisted Drug Design (AIDD) Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific AI-assisted Drug Design (AIDD) Market Size by Region (2018-2023)

8.4 Asia-Pacific AI-assisted Drug Design (AIDD) Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America AI-assisted Drug Design (AIDD) Market Size (2018-2029)

9.2 Latin America AI-assisted Drug Design (AIDD) Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America AI-assisted Drug Design (AIDD) Market Size by Country (2018-2023)

9.4 Latin America AI-assisted Drug Design (AIDD) Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI-assisted Drug Design (AIDD) Market Size (2018-2029)

10.2 Middle East & Africa AI-assisted Drug Design (AIDD) Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Country (2018-2023)

10.4 Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 IBM

11.1.1 IBM Company Detail

11.1.2 IBM Business Overview

11.1.3 IBM AI-assisted Drug Design (AIDD) Introduction

11.1.4 IBM Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.1.5 IBM Recent Development

11.2 Exscientia

11.2.1 Exscientia Company Detail

11.2.2 Exscientia Business Overview

11.2.3 Exscientia AI-assisted Drug Design (AIDD) Introduction

11.2.4 Exscientia Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.2.5 Exscientia Recent Development

11.3 Google(Alphabet)

11.3.1 Google(Alphabet) Company Detail

11.3.2 Google(Alphabet) Business Overview

11.3.3 Google(Alphabet) AI-assisted Drug Design (AIDD) Introduction

11.3.4 Google(Alphabet) Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.3.5 Google(Alphabet) Recent Development

11.4 Microsoft

11.4.1 Microsoft Company Detail

11.4.2 Microsoft Business Overview

11.4.3 Microsoft AI-assisted Drug Design (AIDD) Introduction

11.4.4 Microsoft Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.4.5 Microsoft Recent Development

11.5 Atomwise

11.5.1 Atomwise Company Detail

11.5.2 Atomwise Business Overview

11.5.3 Atomwise AI-assisted Drug Design (AIDD) Introduction

11.5.4 Atomwise Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.5.5 Atomwise Recent Development

11.6 Schrodinger

11.6.1 Schrodinger Company Detail

11.6.2 Schrodinger Business Overview

11.6.3 Schrodinger AI-assisted Drug Design (AIDD) Introduction

11.6.4 Schrodinger Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.6.5 Schrodinger Recent Development

11.7 Aitia

11.7.1 Aitia Company Detail

11.7.2 Aitia Business Overview

11.7.3 Aitia AI-assisted Drug Design (AIDD) Introduction

11.7.4 Aitia Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.7.5 Aitia Recent Development

11.8 Insilico Medicine

11.8.1 Insilico Medicine Company Detail

11.8.2 Insilico Medicine Business Overview

11.8.3 Insilico Medicine AI-assisted Drug Design (AIDD) Introduction

11.8.4 Insilico Medicine Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.8.5 Insilico Medicine Recent Development

11.9 NVIDIA

11.9.1 NVIDIA Company Detail

11.9.2 NVIDIA Business Overview

11.9.3 NVIDIA AI-assisted Drug Design (AIDD) Introduction

11.9.4 NVIDIA Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.9.5 NVIDIA Recent Development

11.10 XtalPi

11.10.1 XtalPi Company Detail

11.10.2 XtalPi Business Overview

11.10.3 XtalPi AI-assisted Drug Design (AIDD) Introduction

11.10.4 XtalPi Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.10.5 XtalPi Recent Development

11.11 BPGbio

11.11.1 BPGbio Company Detail

11.11.2 BPGbio Business Overview

11.11.3 BPGbio AI-assisted Drug Design (AIDD) Introduction

11.11.4 BPGbio Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.11.5 BPGbio Recent Development

11.12 Owkin

11.12.1 Owkin Company Detail

11.12.2 Owkin Business Overview

11.12.3 Owkin AI-assisted Drug Design (AIDD) Introduction

11.12.4 Owkin Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.12.5 Owkin Recent Development

11.13 CytoReason

11.13.1 CytoReason Company Detail

11.13.2 CytoReason Business Overview

11.13.3 CytoReason AI-assisted Drug Design (AIDD) Introduction

11.13.4 CytoReason Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.13.5 CytoReason Recent Development

11.14 Deep Genomics

11.14.1 Deep Genomics Company Detail

11.14.2 Deep Genomics Business Overview

11.14.3 Deep Genomics AI-assisted Drug Design (AIDD) Introduction

11.14.4 Deep Genomics Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.14.5 Deep Genomics Recent Development

11.15 Cloud Pharmaceuticals

11.15.1 Cloud Pharmaceuticals Company Detail

11.15.2 Cloud Pharmaceuticals Business Overview

11.15.3 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Introduction

11.15.4 Cloud Pharmaceuticals Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.15.5 Cloud Pharmaceuticals Recent Development

11.16 BenevolentAI

11.16.1 BenevolentAI Company Detail

11.16.2 BenevolentAI Business Overview

11.16.3 BenevolentAI AI-assisted Drug Design (AIDD) Introduction

11.16.4 BenevolentAI Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.16.5 BenevolentAI Recent Development

11.17 Cyclica

11.17.1 Cyclica Company Detail

11.17.2 Cyclica Business Overview

11.17.3 Cyclica AI-assisted Drug Design (AIDD) Introduction

11.17.4 Cyclica Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.17.5 Cyclica Recent Development

11.18 Verge Genomics

11.18.1 Verge Genomics Company Detail

11.18.2 Verge Genomics Business Overview

11.18.3 Verge Genomics AI-assisted Drug Design (AIDD) Introduction

11.18.4 Verge Genomics Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.18.5 Verge Genomics Recent Development

11.19 Valo Health

11.19.1 Valo Health Company Detail

11.19.2 Valo Health Business Overview

11.19.3 Valo Health AI-assisted Drug Design (AIDD) Introduction

11.19.4 Valo Health Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.19.5 Valo Health Recent Development

11.20 Envisagenics

11.20.1 Envisagenics Company Detail

11.20.2 Envisagenics Business Overview

11.20.3 Envisagenics AI-assisted Drug Design (AIDD) Introduction

11.20.4 Envisagenics Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.20.5 Envisagenics Recent Development

11.21 Euretos

11.21.1 Euretos Company Detail

11.21.2 Euretos Business Overview

11.21.3 Euretos AI-assisted Drug Design (AIDD) Introduction

11.21.4 Euretos Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.21.5 Euretos Recent Development

11.22 BioAge Labs

11.22.1 BioAge Labs Company Detail

11.22.2 BioAge Labs Business Overview

11.22.3 BioAge Labs AI-assisted Drug Design (AIDD) Introduction

11.22.4 BioAge Labs Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.22.5 BioAge Labs Recent Development

11.23 Iktos

11.23.1 Iktos Company Detail

11.23.2 Iktos Business Overview

11.23.3 Iktos AI-assisted Drug Design (AIDD) Introduction

11.23.4 Iktos Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.23.5 Iktos Recent Development

11.24 BioSymetrics

11.24.1 BioSymetrics Company Detail

11.24.2 BioSymetrics Business Overview

11.24.3 BioSymetrics AI-assisted Drug Design (AIDD) Introduction

11.24.4 BioSymetrics Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.24.5 BioSymetrics Recent Development

11.25 Evaxion Biotech

11.25.1 Evaxion Biotech Company Detail

11.25.2 Evaxion Biotech Business Overview

11.25.3 Evaxion Biotech AI-assisted Drug Design (AIDD) Introduction

11.25.4 Evaxion Biotech Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.25.5 Evaxion Biotech Recent Development

11.26 Aria Pharmaceuticals

11.26.1 Aria Pharmaceuticals Company Detail

11.26.2 Aria Pharmaceuticals Business Overview

11.26.3 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Introduction

11.26.4 Aria Pharmaceuticals Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023)

11.26.5 Aria Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global AI-assisted Drug Design (AIDD) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

Table 2. Key Players of Hardware

Table 3. Key Players of Software

Table 4. Key Players of Service

Table 5. Global AI-assisted Drug Design (AIDD) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global AI-assisted Drug Design (AIDD) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 7. Global AI-assisted Drug Design (AIDD) Market Size by Region (2018-2023) & (US$ Million)

Table 8. Global AI-assisted Drug Design (AIDD) Market Share by Region (2018-2023)

Table 9. Global AI-assisted Drug Design (AIDD) Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 10. Global AI-assisted Drug Design (AIDD) Market Share by Region (2024-2029)

Table 11. AI-assisted Drug Design (AIDD) Market Trends

Table 12. AI-assisted Drug Design (AIDD) Market Drivers

Table 13. AI-assisted Drug Design (AIDD) Market Challenges

Table 14. AI-assisted Drug Design (AIDD) Market Restraints

Table 15. Global AI-assisted Drug Design (AIDD) Revenue by Players (2018-2023) & (US$ Million)

Table 16. Global AI-assisted Drug Design (AIDD) Market Share by Players (2018-2023)

Table 17. Global Top AI-assisted Drug Design (AIDD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-assisted Drug Design (AIDD) as of 2022)

Table 18. Ranking of Global Top AI-assisted Drug Design (AIDD) Companies by Revenue (US$ Million) in 2022

Table 19. Global 5 Largest Players Market Share by AI-assisted Drug Design (AIDD) Revenue (CR5 and HHI) & (2018-2023)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players AI-assisted Drug Design (AIDD) Product Solution and Service

Table 22. Date of Enter into AI-assisted Drug Design (AIDD) Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global AI-assisted Drug Design (AIDD) Market Size by Type (2018-2023) & (US$ Million)

Table 25. Global AI-assisted Drug Design (AIDD) Revenue Market Share by Type (2018-2023)

Table 26. Global AI-assisted Drug Design (AIDD) Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 27. Global AI-assisted Drug Design (AIDD) Revenue Market Share by Type (2024-2029)

Table 28. Global AI-assisted Drug Design (AIDD) Market Size by Application (2018-2023) & (US$ Million)

Table 29. Global AI-assisted Drug Design (AIDD) Revenue Market Share by Application (2018-2023)

Table 30. Global AI-assisted Drug Design (AIDD) Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 31. Global AI-assisted Drug Design (AIDD) Revenue Market Share by Application (2024-2029)

Table 32. North America AI-assisted Drug Design (AIDD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. North America AI-assisted Drug Design (AIDD) Market Size by Country (2018-2023) & (US$ Million)

Table 34. North America AI-assisted Drug Design (AIDD) Market Size by Country (2024-2029) & (US$ Million)

Table 35. Europe AI-assisted Drug Design (AIDD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 36. Europe AI-assisted Drug Design (AIDD) Market Size by Country (2018-2023) & (US$ Million)

Table 37. Europe AI-assisted Drug Design (AIDD) Market Size by Country (2024-2029) & (US$ Million)

Table 38. Asia-Pacific AI-assisted Drug Design (AIDD) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

Table 39. Asia-Pacific AI-assisted Drug Design (AIDD) Market Size by Region (2018-2023) & (US$ Million)

Table 40. Asia-Pacific AI-assisted Drug Design (AIDD) Market Size by Region (2024-2029) & (US$ Million)

Table 41. Latin America AI-assisted Drug Design (AIDD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 42. Latin America AI-assisted Drug Design (AIDD) Market Size by Country (2018-2023) & (US$ Million)

Table 43. Latin America AI-assisted Drug Design (AIDD) Market Size by Country (2024-2029) & (US$ Million)

Table 44. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 45. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Country (2018-2023) & (US$ Million)

Table 46. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size by Country (2024-2029) & (US$ Million)

Table 47. IBM Company Detail

Table 48. IBM Business Overview

Table 49. IBM AI-assisted Drug Design (AIDD) Product

Table 50. IBM Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 51. IBM Recent Development

Table 52. Exscientia Company Detail

Table 53. Exscientia Business Overview

Table 54. Exscientia AI-assisted Drug Design (AIDD) Product

Table 55. Exscientia Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 56. Exscientia Recent Development

Table 57. Google(Alphabet) Company Detail

Table 58. Google(Alphabet) Business Overview

Table 59. Google(Alphabet) AI-assisted Drug Design (AIDD) Product

Table 60. Google(Alphabet) Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 61. Google(Alphabet) Recent Development

Table 62. Microsoft Company Detail

Table 63. Microsoft Business Overview

Table 64. Microsoft AI-assisted Drug Design (AIDD) Product

Table 65. Microsoft Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 66. Microsoft Recent Development

Table 67. Atomwise Company Detail

Table 68. Atomwise Business Overview

Table 69. Atomwise AI-assisted Drug Design (AIDD) Product

Table 70. Atomwise Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 71. Atomwise Recent Development

Table 72. Schrodinger Company Detail

Table 73. Schrodinger Business Overview

Table 74. Schrodinger AI-assisted Drug Design (AIDD) Product

Table 75. Schrodinger Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 76. Schrodinger Recent Development

Table 77. Aitia Company Detail

Table 78. Aitia Business Overview

Table 79. Aitia AI-assisted Drug Design (AIDD) Product

Table 80. Aitia Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 81. Aitia Recent Development

Table 82. Insilico Medicine Company Detail

Table 83. Insilico Medicine Business Overview

Table 84. Insilico Medicine AI-assisted Drug Design (AIDD) Product

Table 85. Insilico Medicine Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 86. Insilico Medicine Recent Development

Table 87. NVIDIA Company Detail

Table 88. NVIDIA Business Overview

Table 89. NVIDIA AI-assisted Drug Design (AIDD) Product

Table 90. NVIDIA Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 91. NVIDIA Recent Development

Table 92. XtalPi Company Detail

Table 93. XtalPi Business Overview

Table 94. XtalPi AI-assisted Drug Design (AIDD) Product

Table 95. XtalPi Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 96. XtalPi Recent Development

Table 97. BPGbio Company Detail

Table 98. BPGbio Business Overview

Table 99. BPGbio AI-assisted Drug Design (AIDD) Product

Table 100. BPGbio Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 101. BPGbio Recent Development

Table 102. Owkin Company Detail

Table 103. Owkin Business Overview

Table 104. Owkin AI-assisted Drug Design (AIDD) Product

Table 105. Owkin Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 106. Owkin Recent Development

Table 107. CytoReason Company Detail

Table 108. CytoReason Business Overview

Table 109. CytoReason AI-assisted Drug Design (AIDD) Product

Table 110. CytoReason Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 111. CytoReason Recent Development

Table 112. Deep Genomics Company Detail

Table 113. Deep Genomics Business Overview

Table 114. Deep Genomics AI-assisted Drug Design (AIDD) Product

Table 115. Deep Genomics Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 116. Deep Genomics Recent Development

Table 117. Cloud Pharmaceuticals Company Detail

Table 118. Cloud Pharmaceuticals Business Overview

Table 119. Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Product

Table 120. Cloud Pharmaceuticals Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 121. Cloud Pharmaceuticals Recent Development

Table 122. BenevolentAI Company Detail

Table 123. BenevolentAI Business Overview

Table 124. BenevolentAI AI-assisted Drug Design (AIDD) Product

Table 125. BenevolentAI Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 126. BenevolentAI Recent Development

Table 127. Cyclica Company Detail

Table 128. Cyclica Business Overview

Table 129. Cyclica AI-assisted Drug Design (AIDD) Product

Table 130. Cyclica Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 131. Cyclica Recent Development

Table 132. Verge Genomics Company Detail

Table 133. Verge Genomics Business Overview

Table 134. Verge Genomics AI-assisted Drug Design (AIDD) Product

Table 135. Verge Genomics Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 136. Verge Genomics Recent Development

Table 137. Valo Health Company Detail

Table 138. Valo Health Business Overview

Table 139. Valo Health AI-assisted Drug Design (AIDD) Product

Table 140. Valo Health Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 141. Valo Health Recent Development

Table 142. Envisagenics Company Detail

Table 143. Envisagenics Business Overview

Table 144. Envisagenics AI-assisted Drug Design (AIDD) Product

Table 145. Envisagenics Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 146. Envisagenics Recent Development

Table 147. Euretos Company Detail

Table 148. Euretos Business Overview

Table 149. Euretos AI-assisted Drug Design (AIDD) Product

Table 150. Euretos Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 151. Euretos Recent Development

Table 152. BioAge Labs Company Detail

Table 153. BioAge Labs Business Overview

Table 154. BioAge Labs AI-assisted Drug Design (AIDD) Product

Table 155. BioAge Labs Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 156. BioAge Labs Recent Development

Table 157. Iktos Company Detail

Table 158. Iktos Business Overview

Table 159. Iktos AI-assisted Drug Design (AIDD) Product

Table 160. Iktos Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 161. Iktos Recent Development

Table 162. BioSymetrics Company Detail

Table 163. BioSymetrics Business Overview

Table 164. BioSymetrics AI-assisted Drug Design (AIDD) Product

Table 165. BioSymetrics Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 166. BioSymetrics Recent Development

Table 167. Evaxion Biotech Company Detail

Table 168. Evaxion Biotech Business Overview

Table 169. Evaxion Biotech AI-assisted Drug Design (AIDD) Product

Table 170. Evaxion Biotech Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 171. Evaxion Biotech Recent Development

Table 172. Aria Pharmaceuticals Company Detail

Table 173. Aria Pharmaceuticals Business Overview

Table 174. Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Product

Table 175. Aria Pharmaceuticals Revenue in AI-assisted Drug Design (AIDD) Business (2018-2023) & (US$ Million)

Table 176. Aria Pharmaceuticals Recent Development

Table 177. Research Programs/Design for This Report

Table 178. Key Data Information from Secondary Sources

Table 179. Key Data Information from Primary Sources

List of Figures

Figure 1. Global AI-assisted Drug Design (AIDD) Market Size Comparison by Type (2023-2029) & (US$ Million)

Figure 2. Global AI-assisted Drug Design (AIDD) Market Share by Type: 2022 VS 2029

Figure 3. Hardware Features

Figure 4. Software Features

Figure 5. Service Features

Figure 6. Global AI-assisted Drug Design (AIDD) Market Size Comparison by Application (2023-2029) & (US$ Million)

Figure 7. Global AI-assisted Drug Design (AIDD) Market Share by Application: 2022 VS 2029

Figure 8. Early Drug Discovery Case Studies

Figure 9. Preclinical Phase Case Studies

Figure 10. Clinical Phase Case Studies

Figure 11. Regulatory Approval Case Studies

Figure 12. AI-assisted Drug Design (AIDD) Report Years Considered

Figure 13. Global AI-assisted Drug Design (AIDD) Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 14. Global AI-assisted Drug Design (AIDD) Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 15. Global AI-assisted Drug Design (AIDD) Market Share by Region: 2022 VS 2029

Figure 16. Global AI-assisted Drug Design (AIDD) Market Share by Players in 2022

Figure 17. Global Top AI-assisted Drug Design (AIDD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-assisted Drug Design (AIDD) as of 2022)

Figure 18. The Top 10 and 5 Players Market Share by AI-assisted Drug Design (AIDD) Revenue in 2022

Figure 19. North America AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 20. North America AI-assisted Drug Design (AIDD) Market Share by Country (2018-2029)

Figure 21. United States AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Canada AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Europe AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Europe AI-assisted Drug Design (AIDD) Market Share by Country (2018-2029)

Figure 25. Germany AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 26. France AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. U.K. AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. Italy AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Russia AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Nordic Countries AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Asia-Pacific AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Asia-Pacific AI-assisted Drug Design (AIDD) Market Share by Region (2018-2029)

Figure 33. China AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Japan AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. South Korea AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. Southeast Asia AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. India AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. Australia AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 39. Latin America AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 40. Latin America AI-assisted Drug Design (AIDD) Market Share by Country (2018-2029)

Figure 41. Mexico AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. Brazil AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Middle East & Africa AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Middle East & Africa AI-assisted Drug Design (AIDD) Market Share by Country (2018-2029)

Figure 45. Turkey AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Saudi Arabia AI-assisted Drug Design (AIDD) Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. IBM Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 48. Exscientia Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 49. Google(Alphabet) Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 50. Microsoft Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 51. Atomwise Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 52. Schrodinger Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 53. Aitia Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 54. Insilico Medicine Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 55. NVIDIA Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 56. XtalPi Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 57. BPGbio Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 58. Owkin Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 59. CytoReason Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 60. Deep Genomics Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 61. Cloud Pharmaceuticals Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 62. BenevolentAI Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 63. Cyclica Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 64. Verge Genomics Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 65. Valo Health Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 66. Envisagenics Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 67. Euretos Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 68. BioAge Labs Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 69. Iktos Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 70. BioSymetrics Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 71. Evaxion Biotech Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 72. Aria Pharmaceuticals Revenue Growth Rate in AI-assisted Drug Design (AIDD) Business (2018-2023)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-0V8134

Sat May 11 00:00:00 UTC 2024

Add to Cart

Global Marine Biopharmaceutical Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2C6281

Sat May 11 00:00:00 UTC 2024

Add to Cart

Global Medicine Bottle Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-39C4098

Sat May 11 00:00:00 UTC 2024

Add to Cart

Global UV Sterilizer For Medical Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10O7850

Sat May 11 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global AI-assisted Drug Design (AIDD) Market Research Report 2023

Published Date: October 2023

Report Code: QYRE-Auto-28S14227

Global AI-assisted Drug Design (AIDD) Market Research Report 2023

FEATURED COMPANIES

AI-assisted Drug Design (AIDD) Market Size

AI-assisted Drug Design (AIDD) Market

Report Scope

Scope of AI-assisted Drug Design (AIDD) Market Report

FAQ for this report

How fast is AI-assisted Drug Design (AIDD) Market growing?

What is the AI-assisted Drug Design (AIDD) Market size in 2029?

Who are the main players in the AI-assisted Drug Design (AIDD) Market report?

What are the Application segmentation covered in the AI-assisted Drug Design (AIDD) Market report?

What are the Type segmentation covered in the AI-assisted Drug Design (AIDD) Market report?

FEATURED COMPANIES

RELATED REPORTS